Rewiring immune landscapes: How neoadjuvant endocrine therapy shapes the tumor microenvironment in ER⁺/HER2-negative breast cancer
European Journal of Cancer · 2026-03 · 237 · 116356
DOI: 10.1016/j.ejca.2026.116356 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von G. Oner und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Oner, G., Praet, M., Devi, G., Canturk, N., Altintas, S., Berneman, Z., Tjalma, W., Koljenovic, S., & Dam, P. V. (2026). Rewiring immune landscapes: How neoadjuvant endocrine therapy shapes the tumor microenvironment in ER⁺/HER2-negative breast cancer. European Journal of Cancer, 237, 116356. https://doi.org/10.1016/j.ejca.2026.116356
Vancouver
Oner G, Praet M, Devi G, Canturk N, Altintas S, Berneman Z, et al. Rewiring immune landscapes: How neoadjuvant endocrine therapy shapes the tumor microenvironment in ER⁺/HER2-negative breast cancer. European Journal of Cancer. 2026;237:116356. doi:10.1016/j.ejca.2026.116356
BibTeX
@article{Oner2026,
author = {Oner, G. and Praet, M. and Devi, G. and Canturk, N.Z. and Altintas, S. and Berneman, Z. and Tjalma, W. and Koljenovic, S. and Dam, P.A. van},
title = {Rewiring immune landscapes: How neoadjuvant endocrine therapy shapes the tumor microenvironment in ER⁺/HER2-negative breast cancer},
journal = {European Journal of Cancer},
year = {2026},
volume = {237},
pages = {116356},
doi = {10.1016/j.ejca.2026.116356}
}
EUVIMED